“LRRK2: Autophagy and Lysosomal Activity”
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
) gene was identified as the most common genetic cause for Parkinson's disease (PD). The two most common mutations are the LRRK2-G2019S, located in the kinase domain, and the LRRK2-R1441C, located in the ROC-COR domain. While the LRRK2-G2019S mutation is associated with increased kinase activity, the LRRK2-R1441C exhibits a decreased GTPase activity and altered kinase activity. Multiple lines of evidence have linked the LRRK2 protein with a role in the autophagy pathway and with lysosomal activity in neurons. Neurons rely heavily on autophagy to recycle proteins and process cellular waste due to their post-mitotic state. Additionally, lysosomal activity decreases with age which can potentiate the accumulation of α-synuclein, the pathological hallmark of PD, and subsequently lead to the build-up of Lewy bodies (LBs) observed in this disorder. This review provides an up to date summary of the LRRK2 field to understand its physiological role in the autophagy pathway in neurons and related cells. Careful assessment of how LRRK2 participates in the regulation of phagophore and autophagosome formation, autophagosome and lysosome fusion, lysosomal maturation, maintenance of lysosomal pH and calcium levels, and lysosomal protein degradation are addressed. The autophagy pathway is a complex cellular process and due to the variety of LRRK2 models studied in the field, associated phenotypes have been reported to be seemingly conflicting. This review provides an in-depth discussion of different models to assess the normal and disease-associated role of the LRRK2 protein on autophagic function. Given the importance of the autophagy pathway in Parkinson's pathogenesis it is particularly relevant to focus on the role of LRRK2 to discover novel therapeutic approaches that restore lysosomal protein degradation homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
Bae, E.-J., Kim, D.-K., Kim, C., Mante, M., Adame, A., Rockenstein, E., Ulusoy, A., Klinkenberg, M., Jeong, G. R., Bae, J. R., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05958-z · Cited by 149 · cited 1×
“…showed that administering the HG-10-102-01 LRRK2 kinase inhibitor intraperitoneally to transgenic mice overexpressing human WT α -synuclein significantly reduced trans-axonal α -synuclein aggregates and phosphorylated α -synuclein in different brain regions of transgenic mice (Bae et al., 2018).”
BackgroundRetractedGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894 · cited 1×
“The G2019S mutation presents a penetrance ranging from 17% at 50 years old to 85% at 70 years old, and the R1441C mutation presents with more severe phenotypes (Healy et al., 2008; Kluss et al., 2019).”
Mechanism and medical implications of mammalian autophagy
Dikic, I., & Elazar, Z. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0003-4 · Cited by 2,771 · cited 1×
“VPS34 converts phosphoinositol into phosphoinositol-3-phosphate [PI(3)P] which in turn binds to WIPI proteins, to recruit autophagy-related proteins (Atg) (Behrends et al., 2010; Dikic and Elazar, 2018).”
BackgroundHow to Interpret LC3 Immunoblotting
Mizushima, N., & Yoshimori, T. (2007) · Autophagy · doi:10.4161/auto.4600 · Cited by 2,669
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 3×
“Furthermore, α -synuclein can be degraded via proteasome, CMA, and autophagy in neurons (Webb et al., 2003; Cuervo et al., 2004; Vogiatzi et al., 2008).”
BackgroundInternational Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R. L. A., Kim, J., May, J., Tocilescu, M. A., Liu, W., Ko, H. S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911187107 · Cited by 1,616
Network organization of the human autophagy system
Behrends, C., Sowa, M. E., Gygi, S. P., & Harper, J. W. (2010) · Nature · doi:10.1038/nature09204 · Cited by 1,554 · cited 1×
“VPS34 converts phosphoinositol into phosphoinositol-3-phosphate [PI(3)P] which in turn binds to WIPI proteins, to recruit autophagy-related proteins (Atg) (Behrends et al., 2010; Dikic and Elazar, 2018).”
BackgroundRole of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks
Alers, S., Löffler, A. S., Wesselborg, S., & Stork, B. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06159-11 · Cited by 1,483
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Research works printed but not linked: 121
- Alcalay, 2015, Glucocerebrosidase activity in Parkinson’s disease with and without GBA mutations., Brain, 138, 2648, 10.1093/brain/awv179 · DOI · Paper page
- Alegre-Abarrategui, 2009, LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model., Hum. Mol. Genet., 18, 4022, 10.1093/hmg/ddp346 · DOI · Paper page
- Antony, 2013, The hallmarks of Parkinson’s disease., FEBS J., 280, 5981, 10.1111/febs.12335 · DOI · Paper page
- Atashrazm, 2016, LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives., Clin. Pharmacol. Adv. Appl., 8, 177, 10.2147/CPAA.S102191 · DOI · Paper page
- Bahmad, 2017, Modeling human neurological and neurodegenerative diseases: from induced pluripotent stem cells to neuronal differentiation and its applications in neurotrauma., Front,. Mol. Neurosci., 10, 10.3389/fnmol.2017.00050 · DOI
- Bandyopadhyay, 2008, The Chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane., Mol. Cell. Biol., 28, 5747, 10.1128/mcb.02070-07 · DOI · Paper page
- Bang, 2016, LRRK2 interferes with aggresome formation for autophagic clearance., Mol. Cell. Neurosci., 75, 71, 10.1016/j.mcn.2016.06.007 · DOI
- Beavan, 2013, Glucocerebrosidase mutations and the pathogenesis of Parkinson disease., Ann. Med., 45, 511, 10.3109/07853890.2013.849003 · DOI · Paper page
- Beilina, 2014, Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease., Proc. Natl. Acad. Sci. U.S.A., 111, 2626, 10.1073/pnas.1318306111 · DOI · Paper page
- Berwick, 2019, LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same., Mol. Neurodegener., 14, 1, 10.1186/s13024-019-0344-2 · DOI · Paper page
- Blauwendraat, 2020, Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia., Brain, 143, 234, 10.1093/brain/awz350 · DOI · Paper page
- Bravo-San Pedro, 2013, The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway., Cell. Mol. Life Sci., 70, 121, 10.1007/s00018-012-1061-y · DOI · Paper page
- Caesar, 2015, Changes in actin dynamics and F-actin structure both in synaptoneurosomes of LRRK2(R1441G) mutant mice and in primary human fibroblasts of LRRK2(G2019S) mutation carriers., Neuroscience, 284, 311, 10.1016/j.neuroscience.2014.09.070 · DOI
- Chan, 2007, siRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy., J. Biol Chem., 282, 25464, 10.1074/jbc.M703663200 · DOI · Paper page
- Chen, 2018, LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson’s disease: a review Julie Y.H. Chan., J. Biomed. Sci., 25, 1, 10.1186/s12929-018-0454-0 · DOI
- Cherubini, 2018, Convergent pathways in Parkinson’s disease., Cell Tissue Res., 373, 79, 10.1007/s00441-017-2700-2 · DOI
- Cho, 2014, Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER –Golgi export., EMBO J., 33, 2314, 10.15252/embj.201487807 · DOI
- Chu, 2009, Alterations in lysosomal and proteasomal markers in Parkinson’s disease: relationship to alpha-synuclein inclusions., Neurobiol. Dis., 35, 385, 10.1016/j.nbd.2009.05.023 · DOI · Paper page
- Chung, 2013, Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons., Science, 342, 983, 10.1126/science.1245296 · DOI · Paper page
- Colla, 2012, Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo., J. Neurosci., 32, 3301, 10.1523/JNEUROSCI.5368-11.2012 · DOI · Paper page
- Connor-Robson, 2019, An integrated transcriptomics and proteomics analysis reveals functional endocytic dysregulation caused by mutations in LRRK2., Neurobiol. Dis., 127, 512, 10.1016/j.nbd.2019.04.005 · DOI · Paper page
- Cookson, 2016, Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson’s disease., Biochem. Soc. Trans., 44, 1603, 10.1042/BST20160228 · DOI · Paper page
- Cookson, 2017, Mechanisms of mutant LRRK2 neurodegeneration., Adv. Neurobiol., 14, 227, 10.1007/978-3-319-49969-7_12 · DOI
- Deretic, 2011, Autophagy in immunity and cell-autonomous defense against intracellular microbes., Immunol. Rev., 240, 92, 10.1111/j.1600-065X.2010.00995.x · DOI · Paper page
- Dodson, 2014, Novel ethyl methanesulfonate (EMS)-induced null alleles of the Drosophila homolog of LRRK2 reveal a crucial role in endolysosomal functions and autophagy in vivo., Dis. Models Mech., 7, 1351, 10.1242/dmm.017020 · DOI · Paper page
- Dodson, 2012, Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning., Hum. Mol. Genet., 21, 1350, 10.1093/hmg/ddr573 · DOI · Paper page
- Dorsey, 2007, Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030., Neurology, 68, 384, 10.1212/01.wnl.0000247740.47667.03 · DOI · Paper page
- Eguchi, 2018, LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis., Proc. Natl. Acad. Sci. U.S.A., 115, E9115, 10.1073/pnas.1812196115 · DOI · Paper page
- Fernandes, 2016, ER Stress and autophagic perturbations lead to elevated extracellular α-Synuclein in GBA-N370S Parkinson’s iPSC-derived dopamine neurons., Stem Cell Rep., 6, 342, 10.1016/j.stemcr.2016.01.013 · DOI · Paper page
- Ghislat, 2013, Ca2+-sensor proteins in the autophagic and endocytic traffic., Curr. Protein Peptide Sci., 14, 97, 10.2174/13892037112139990033 · DOI
- Giaime, 2017, Age-dependent dopaminergic neurodegeneration and impairment of the autophagy-lysosomal pathway in LRRK-deficient mice., Neuron, 96, 796.e6, 10.1016/j.neuron.2017.09.036 · DOI · Paper page
- Giménez-Xavier, 2008, LC3-I conversion to LC3-II does not necessarily result in complete autophagy., Int. J. Mol. Med., 22, 781, 10.3892/ijmm_00000085 · DOI · Paper page
- Godena, 2014, Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations., Nat. Commun., 5, 10.1038/ncomms6245 · DOI · Paper page
- Gómez-Suaga, 2012, Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP., Hum. Mol. Genet., 21, 511, 10.1093/hmg/ddr481 · DOI · Paper page
- Guaitoli, 2016, First model of dimeric LRRK2: the challenge of unrevealing the structure of a multidomain Parkinson’s-associated protein., Biochem. Soc. Trans., 44, 1635, 10.1042/BST20160226 · DOI
- Han, 2012, Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway., Cell, 149, 410, 10.1016/j.cell.2012.02.044 · DOI · Paper page
- Hardy, 2010, Genetic analysis of pathways to parkinson disease., Neuron, 68, 201, 10.1016/j.neuron.2010.10.014 · DOI · Paper page
- Härtlova, 2018, LRRK2 is a negative regulator of Mycobacterium tuberculosis phagosome maturation in macrophages., EMBO J., 37, 1, 10.15252/embj.201798694 · DOI · Paper page
- Healy, 2008, Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson’s disease: a case-control study., Lancet Neurol., 7, 583, 10.1016/S1474-4422(08)70117-0 · DOI · Paper page
- Henderson, 2019, LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice., Acta Neuropathol. Commun., 7, 1, 10.1186/s40478-019-0679-5 · DOI · Paper page
- Higashi, 2009, Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease., J. Neuropathol. Exp. Neurol., 68, 994, 10.1097/NEN.0b013e3181b44ed8 · DOI · Paper page
- Ho, 2018, LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase., Cell Biochem. and Func., 36, 431, 10.1002/cbf.3364 · DOI
- Ho, 2019, Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA)., Autophagy, 1, 10.1080/15548627.2019.1603545 · DOI · Paper page
- Hockey, 2015, Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition., J. Cell Sci., 128, 232, 10.1242/jcs.164152 · DOI · Paper page
- Hu, 2018, LRRK2 G2019S mutation inhibits degradation of α-synuclein in an in vitro model of Parkinson’s Disease., Curr. Med. Sci., 38, 1012, 10.1007/s11596-018-1977-z · DOI
- Hu, 2015, The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration., Transl. Neurodegener., 4, 1, 10.1186/s40035-015-0041-1 · DOI · Paper page
- Johnson, 2019, Triggers, facilitators, and aggravators: redefining Parkinson’s Disease pathogenesis., Trends Neurosci., 42, 4, 10.1016/j.tins.2018.09.007 · DOI · Paper page
- Juárez-Flores, 2018, Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson’s disease., J. Transl. Med., 16, 1, 10.1186/s12967-018-1526-3 · DOI
- Kalogeropulou, 2018, P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity., Biochem. J., 475, 1271, 10.1042/BCJ20170699 · DOI
- Karuppagounder, 2016, LRRK2 G2019S transgenic mice display increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mediated neurotoxicity., J. Chem. Neuroanat., 76, 90, 10.1016/j.jchemneu.2016.01.007 · DOI
- Kimura, 2015, TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity., J. Cell Biol., 210, 973, 10.1083/jcb.201503023 · DOI · Paper page
- Klein, 2012, Genetics of Parkinson’s Disease., Cold Spring Harbor Perspect. Med., 2, 10.1101/cshperspect.a008888 · DOI · Paper page
- Kluss, 2019, LRRK2 links genetic and sporadic Parkinson’s disease., Biochem. Soc. Trans., 47, 651, 10.1042/BST20180462 · DOI · Paper page
- Lee, 2017, LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson’s disease., Biochem. Soc. Trans., 45, 131, 10.1042/BST20160262 · DOI · Paper page
- Lee, 2013, Autophagic failure promotes the exocytosis and intercellular transfer of α-synuclein., Exp. Mol. Med., 45, 1, 10.1038/emm.2013.45 · DOI · Paper page
- Lewis, 2007, The R1441C mutation of LRRK2 disrupts GTP hydrolysis., Biochem. Biophys. Res. Commun., 357, 668, 10.1016/j.bbrc.2007.04.006 · DOI · Paper page
- Li, 2017, Structural basis of dual Ca 2+ /pH regulation of the endolysosomal TRPML1 channel., Nat. Struc. Mol. Biol., 24, 205, 10.1038/nsmb.3362 · DOI · Paper page
- Li, 2009, Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson’s disease., Nat. Neurosci., 12, 826, 10.1038/nn.2349 · DOI · Paper page
- Liu, 2016, P62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation., Cell. Mol. Biol. Lett., 21, 1, 10.1186/s11658-016-0031-z · DOI · Paper page
- MacLeod, 2006, The familial parkinsonism gene LRRK2 regulates neurite process morphology., Neuron, 52, 587, 10.1016/j.neuron.2006.10.008 · DOI · Paper page
- MacLeod, 2013, RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson’s Disease risk., Neuron, 77, 425, 10.1016/j.neuron.2012.11.033 · DOI · Paper page
- Mamais, 2018, Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson’s disease brains with Lewy body pathology., Brain Res., 1701, 75, 10.1016/j.brainres.2018.07.023 · DOI · Paper page
- Manzoni, 2017, The LRRK2-macroautophagy axis and its relevance to Parkinson’s disease., Biochem. Soc. Trans., 45, 155, 10.1042/BST20160265 · DOI · Paper page
- Manzoni, 2017, LRRK2 and autophagy., Adv. Neurobiol., 14, 89, 10.1007/978-3-319-49969-7_5 · DOI
- Manzoni, Inhibition of LRRK2 kinase activity stimulates macroautophagy., Biochim. Biophys. Acta Mol. Cell Rese., 1833, 2900, 10.1016/j.bbamcr.2013.07.020 · DOI · Paper page
- Manzoni, Pathogenic parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation., Biochem. Biophys. Res. Commun., 441, 862, 10.1016/j.bbrc.2013.10.159 · DOI · Paper page
- Manzoni, 2018, mTOR independent alteration in ULK1 Ser758 phosphorylation following chronic LRRK2 kinase inhibition., Biosci. Rep., 38, 1, 10.1042/BSR20171669 · DOI
- Manzoni, 2016, MTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1., Sci. Res., 6, 1, 10.1038/srep35106 · DOI · Paper page
- McGlinchey, 2015, Cysteine cathepsins are essential in lysosomal degradation of α-synuclein., Proc. Natl. Acad. Sci. U.S.A., 112, 9322, 10.1073/pnas.1500937112 · DOI · Paper page
- Meley, 2006, AMP-activated protein kinase and the regulation of autophagic proteolysis., J. Biol. Chem., 281, 34870, 10.1074/jbc.M605488200 · DOI · Paper page
- Mizushima, 2002, Autophagosome formation in mammalian cells., Cell Struc. Func., 27, 421, 10.1247/csf.27.421 · DOI · Paper page
- Mortiboys, 2010, Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2., Neurology, 75, 2017, 10.1212/WNL.0b013e3181ff9685 · DOI · Paper page
- Nichols, 2010, 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson’s disease-associated mutations and regulates cytoplasmic localization., Biochem. J., 404, 393, 10.1042/BJ20100483 · DOI · Paper page
- Noda, 1998, Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast., J. Biol. Chem., 273, 3963, 10.1074/jbc.273.7.3963 · DOI · Paper page
- Obergasteiger, 2019, Kinase inhibition of G2019S-LRRK2 restores autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions., BioRxiv, 10.1101/707273 · doi:10.1101/707273
- Obergasteiger, 2018, A new hypothesis for Parkinson’s disease pathogenesis: GTPase-p38 MAPK signaling and autophagy as convergence points of etiology and genomics., Mol. Neurodegener., 13, 1, 10.1186/s13024-018-0273-5 · DOI
- Outeiro, 2019, LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders?, Biochem. Soc. Trans., 47, 827, 10.1042/bst20180466 · DOI
- Paisán-Ruíz, 2004, Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease., Neuron, 44, 595, 10.1016/j.neuron.2004.10.023 · DOI · Paper page
- Pan, 2017, Parkinson’s disease-associated LRRK2 hyperactive kinase mutant disrupts synaptic vesicle trafficking in ventral midbrain neurons., J. Neurosci., 37, 11366, 10.1523/JNEUROSCI.0964-17.2017 · DOI · Paper page
- Parisiadou, 2014, LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity., Nat. Neurosci., 17, 367, 10.1038/nn.3636 · DOI · Paper page
- Park, 2016, Interplay between leucine-rich repeat kinase 2 (LRRK2) and p62/SQSTM-1 in Selective Autophagy., PLoS One, 11, 10.1371/journal.pone.0163029 · DOI
- Plowey, 2008, Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells., J. Neurochem., 105, 1048, 10.1111/j.1471-4159.2008.05217.x · DOI · Paper page
- Polymeropoulos, 1997, Mutation in the α-synuclein gene identified in families with Parkinson’s disease., Science, 276, 2045, 10.1126/science.276.5321.2045 · DOI · Paper page
- Pupyshev, 2018, Suppression of autophagy in the brain of transgenic mice with overexpression of A53T-mutant α-synuclein as an early event at synucleinopathy progression., Neurosci. Lett., 672, 140, 10.1016/j.neulet.2017.12.001 · DOI
- Ryan, 2013, Isogenic human iPSC Parkinson’s model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription., Cell, 155, 10.1016/j.cell.2013.11.009 · DOI · Paper page
- Saez-Atienzar, 2014, The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling., Cell Death Dis., 5, 1, 10.1038/cddis.2014.320 · DOI · Paper page
- Saha, 2015, Mutations in LRRK2 potentiate age-related impairment of autophagic flux., Mol. Neurodegener., 10, 10.1186/s13024-015-0022-y · DOI · Paper page
- Sánchez-Danés, 2012, Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson’s disease., EMBO Mol. Med., 4, 380, 10.1002/emmm.201200215 · DOI · Paper page
- Sanyal, 2020, Lysosome and inflammatory defects in GBA1 -mutant astrocytes are normalized by LRRK2 inhibition., Mov. Disord., 27994, 10.1002/mds.27994 · DOI · Paper page
- Schapansky, 2018, Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons., Neurobiol. Dis., 111, 26, 10.1016/j.nbd.2017.12.005 · DOI · Paper page
- Schapansky, 2015, The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson’s disease., Neuroscience, 302, 74, 10.1016/j.neuroscience.2014.09.049 · DOI · Paper page
- Schneider, 2017, Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature., Mov. Disord., 32, 1504, 10.1002/mds.27193 · DOI · Paper page
- Shani, 2019, Physiological and pathological roles of LRRK2 in the nuclear envelope integrity., Hum. Mol. Genet., 28, 3982, 10.1093/hmg/ddz245 · DOI
- Singleton, 2013, The genetics of Parkinson’s disease: progress and therapeutic implications., Mov. Disord., 28, 14, 10.1002/mds.25249 · DOI · Paper page
- Sloan, 2016, LRRK2 BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function., Hum. Mol. Genet., 25, 951, 10.1093/hmg/ddv628 · DOI · Paper page
- Smith, 2005, Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity., Hum. Mol. Gene., 14, 3801, 10.1093/hmg/ddi396 · DOI · Paper page
- Spillantini, 1997, α-Synuclein in lewy bodies., Nature, 388, 839, 10.1038/42166 · DOI · Paper page
- Steger, 2016, Phosphoproteomics reveals that Parkinson’s disease kinase LRRK2 regulates a subset of Rab GTPases., eLife, 5, 1, 10.7554/eLife.12813.001 · doi:10.7554/elife.12813.001
- Su, 2015, Threonine 56 phosphorylation of Bcl-2 is required for LRRK2 G2019S-induced mitochondrial depolarization and autophagy., Biochim. Biophys. Acta Mol. Basis Dis., 1852, 12, 10.1016/j.bbadis.2014.11.009 · DOI · Paper page
- Su, 2013, Inhibition of excessive mitochondrialfissionreduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation., Hum. Mol. Genet., 22, 4545, 10.1093/hmg/ddt301 · DOI · Paper page
- Taguchi, 2017, Glucosylsphingosine promotes α-synuclein pathology in mutant GBA-associated parkinson’s disease., J. Neurosci., 37, 9617, 10.1523/JNEUROSCI.1525-17.2017 · DOI · Paper page
- Tong, 2012, Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway., Mol. Neurodegener., 7, 1, 10.1186/1750-1326-7-222230652 · doi:10.1186/1750-1326-7-222230652
- Tong, 2010, Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of α-synuclein, and apoptotic cell death in aged mice., Proc. Natl. Acad. Sci. U. S.A., 107, 9879, 10.1073/pnas.1004676107 · DOI · Paper page
- Tsika, 2014, Conditional expression of Parkinson’s disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration., Neurobiol. Dis., 71, 345, 10.1016/j.nbd.2014.08.027 · DOI
- Volpicelli-Daley, 2016, G2019s-LRRK2 expression augments α-synuclein sequestration into inclusions in neurons., J. Neurosci., 36, 7415, 10.1523/JNEUROSCI.3642-15.2016 · DOI · Paper page
- Wallings, 2019, LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function., Hum. Mol. Genet., 28, 2696, 10.1093/hmg/ddz088 · DOI · Paper page
- Wallings, 2015, Cellular processes associated with LRRK2 function and dysfunction., FEBS J., 282, 2806, 10.1111/febs.13305 · DOI · Paper page
- Wallings, 2019, LRRK2 regulation of immune-pathways and inflammatory disease., Biochem. Soc. Trans., 47, 1581, 10.1042/BST20180463 · DOI · Paper page
- Walter, 2019, Neural stem cells of Parkinson’s Disease Patients exhibit aberrant mitochondrial morphology and functionality., Stem Cell Rep., 12, 878, 10.1016/j.stemcr.2019.03.004 · DOI · Paper page
- Wang, 2015, Alpha-synuclein toxicity in the early secretory pathway: how it drives neurodegeneration in parkinsons disease., Front. Neurosci., 9, 10.3389/fnins.2015.00433 · DOI
- Wang, 2017, Destructive cellular paths underlying familial and sporadic Parkinson disease converge on mitophagy., Autophagy, 13, 1998, 10.1080/15548627.2017.1327511 · DOI
- Wang, 2012, LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1., Hum. Mol. Genet., 21, 1931, 10.1093/hmg/dds003 · DOI · Paper page
- Xilouri, 2013, α-Synuclein and protein degradation systems: a reciprocal relationship., Mol. Neurobiol., 47, 537, 10.1007/s12035-012-8341-2 · DOI · Paper page
- Yahalom, 2019, Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson’s disease: risk estimates and genotype-phenotype correlations., Park. Relat. Disord., 62, 179, 10.1016/j.parkreldis.2018.12.014 · DOI
- Ysselstein, 2019, LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients., Nat. Commun., 10, 1, 10.1038/s41467-019-13413-w · DOI · Paper page
- Yue, 2015, Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice., Neurobiol. Dis., 78, 172, 10.1016/j.nbd.2015.02.031 · DOI · Paper page
- Yun, 2015, An early endosome regulator. Rab5b, is an LRRK2 kinase substrate., J. Biochem., 157, 485, 10.1093/jb/mvv005 · DOI · Paper page
- Zambon, 2019, Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson’s iPSC-derived dopamine neurons., Hum. Mol. Genet., 28, 2001, 10.1093/hmg/ddz038 · DOI · Paper page
- Zeng, 2018, Cellular and molecular basis of neurodegeneration in Parkinson disease., Front. Aging Neurosci., 10, 10.3389/fnagi.2018.00109 · DOI · Paper page
- Zhou, 2016, Autophagy activation prevents sevoflurane-induced neurotoxicity in H4 human neuroglioma cells., Acta Pharmacol. Sin., 37, 580, 10.1038/aps.2016.6 · DOI
- Zimprich, 2004, Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology., Neuron, 44, 601, 10.1016/j.neuron.2004.11.005 · DOI · Paper page
Cited by
di Domenico, A., Carola, G., Calatayud, C., Pons-Espinal, M., Muñoz, J. P., Richaud-Patin, Y., Fernandez-Carasa, I., Gut, M., Faella, A., Parameswaran, J., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.12.011 · Cited by 372
Impaired dopamine release in Parkinson’s disease
Cramb, K. M. L., Beccano-Kelly, D., Cragg, S. J., & Wade-Martins, R. (2023) · Brain · doi:10.1093/brain/awad064 · Cited by 207
“A major protein degradation pathway, autophagy, is critical to regulating protein turnover in neurons and has been connected to Parkinson’s disease-related mutations including SNCA, LRRK2, VPS35, parkin, Pink1 and DJ-1.(6,141)”
BackgroundSelf-citationKochman, U., Sitka, H., Kuźniar, J., Czaja, M., Kozubek, P., Beszłej, J. A., & Leszek, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05417-z · Cited by 60
Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B
Pal, P., Taylor, M., Lam, P. Y., Tonelli, F., Hecht, C. A., Lis, P., Nirujogi, R. S., Phung, T. K., Yeshaw, W. M., Jaimon, E., et al. (2023) · Science Advances · doi:10.1126/sciadv.adj1205 · Cited by 36
Flinkman, D., Hong, Y., Gnjatovic, J., Deshpande, P., Ortutay, Z., Peltonen, S., Kaasinen, V., James, P., & Coffey, E. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-023-00460-w · Cited by 20
Metadata
- Authors
- Madureira, M., Connor-Robson, N., & Wade-Martins, R.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2020-05-25
- Volume
- 14
- Pages
- 498-498
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W3027854502
- Cited by
- 137
- References
- 30
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: “LRRK2: Autophagy and Lysosomal Activity”. https://app.cochat.ai/papers/10.3389/fnins.2020.00498
- The paper
- Madureira, M., Connor-Robson, N., & Wade-Martins, R. (2020). “LRRK2: Autophagy and Lysosomal Activity”. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2020.00498
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.